Syncona Portfolio Ltd Long-Term Concentrated

CIK: 0001725042 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 10, 2022

Total Value ($000): $70,379 (100.0% shares, 0.0% debt)

Holdings (4)

— ACHILLES THERAPEUTICS PLC 39.7%

Value ($000) $27,939 Shares 11,086,909 Est. Cost $5.01 Unrealized —

AUTL AUTOLUS THERAPEUTICS PLC 29.5%

Value ($000) $20,792 Shares 7,346,829 Est. Cost $5.19 Unrealized —

— FREELINE THERAPEUTICS HLDGS 27.4%

Value ($000) $19,307 Shares 21,997,620 Est. Cost $0.50 Unrealized —

ADAPY ADAPTIMMUNE THERAPEUTICS PLC 3.3%

Value ($000) $2,341 Shares 1,377,294 Est. Cost $3.75 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ACHILLES THERAPEUTICS PLC	11,086,909	$27,939	39.7%	$5.01	—	SPONSORED ADS	00449L102
AUTL	AUTOLUS THERAPEUTICS PLC	7,346,829	$20,792	29.5%	$5.19	—	SPON ADS	05280R100
—	FREELINE THERAPEUTICS HLDGS	21,997,620	$19,307	27.4%	$0.50	—	SPONSORED ADS	35655L107
ADAPY	ADAPTIMMUNE THERAPEUTICS PLC	1,377,294	$2,341	3.3%	$3.75	—	SPONDS ADR	00653A107